MIR4299

gene
On this page

Also known as hsa-mir-4299

Summary

MIR4299 (microRNA 4299, HGNC:38329) is a microRNA gene on chromosome 11p15.4.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 100423026 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:38329
Approved symbolMIR4299
NamemicroRNA 4299
Location11p15.4
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-4299
Ensembl geneENSG00000266645
Ensembl biotypemiRNA
Entrez100423026
RNAcentralURS000075EC98 — miRNA, 72 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000577899

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000577899 — 1 exons

ExonStartEnd
ENSE000027313571165665111656722

Expression profiles

Bgee: expression breadth broad, 33 present calls, max score 85.18.

Top tissues by expression

33 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
placentaUBERON:000198785.18gold quality
intestineUBERON:000016083.92gold quality
stomachUBERON:000094575.54gold quality
heartUBERON:000094872.87gold quality
putamenUBERON:000187472.34gold quality
heart left ventricleUBERON:000208472.32gold quality
endometriumUBERON:000129570.55gold quality
lower esophagus muscularis layerUBERON:003583368.37gold quality
right atrium auricular regionUBERON:000663167.34gold quality
substantia nigraUBERON:000203867.18gold quality
dorsolateral prefrontal cortexUBERON:000983466.01gold quality
tibial arteryUBERON:000761065.02gold quality
Ammon’s hornUBERON:000195464.88gold quality
omental fat padUBERON:001041464.13gold quality
hypothalamusUBERON:000189863.86gold quality
right frontal lobeUBERON:000281063.73gold quality
nucleus accumbensUBERON:000188263.11gold quality
left uterine tubeUBERON:000130363.07gold quality
C1 segment of cervical spinal cordUBERON:000646962.78gold quality
prostate glandUBERON:000236762.67gold quality
subcutaneous adipose tissueUBERON:000219062.56gold quality
tibial nerveUBERON:000132361.87gold quality
skin of legUBERON:000151161.60gold quality
skin of abdomenUBERON:000141661.43gold quality
brainUBERON:000095561.19gold quality
left ovaryUBERON:000211960.67gold quality
Brodmann (1909) area 9UBERON:001354057.98gold quality
pituitary glandUBERON:000000756.13gold quality
caudate nucleusUBERON:000187355.35gold quality
testisUBERON:000047344.23gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.49

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 4)

  • The low level of miR-4299 expression is correlated with less chemotherapy resistance and better survival of colon cancer patients. (PMID:26626874)
  • This study implies the potential therapeutic application of miR-4299 and ST6GALNAC4 in modulating the invasion and tumorigenicity of follicular thyroid carcinoma cell (PMID:26715099)
  • results indicate that miR-4299 may be a candidate independent marker for NSCLC prognosis and suppressed the progression of NSCLC by modulating the activation of PTEN/AKT/PI3K signaling pathway. (PMID:29917192)
  • miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17. (PMID:36565360)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.